{"id":30397,"date":"2012-07-12T14:10:38","date_gmt":"2012-07-12T18:10:38","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?post_type=voices&p=30397"},"modified":"2012-07-12T14:10:38","modified_gmt":"2012-07-12T18:10:38","slug":"selections-from-richard-lehmans-literature-review-july-12th","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2012\/07\/12\/selections-from-richard-lehmans-literature-review-july-12th\/","title":{"rendered":"Selections from Richard Lehman\u2019s Literature Review: July 12th"},"content":{"rendered":"

CardioExchange is pleased to reprint selections from Dr. Richard Lehman\u2019s\u00a0weekly journal review blog<\/a>\u00a0at\u00a0BMJ.com<\/a>. Selected summaries are relevant to our audience, but we encourage members to engage with the\u00a0entire blog<\/a>.<\/em><\/p>\n

Arch Intern Med\u00a0 25 June 2012\u00a0 Vol 172<\/strong><\/p>\n

Sex Differences in the Protective Effect of Statins (pg. 909):<\/strong>\u00a0 The Archives are about to mutate into JAMA Internal Medicine, but I generally find them a better read than JAMA proper. One reason is the abundance of lively comment\u2014and in the case of this paper on sex differences in the protective effect of statins<\/a>, I find the comment more believable than the paper. This is a meta-analysis of eleven double-blinded RCTs of statin therapy for the prevention of recurrent cardiovascular events, and purports to show that although statins are as good at preventing recurrent cardiac events in women as in men, they do not prevent stroke or reduce all-cause mortality in women. Two British luminaries contest this<\/a>, arguing that the literature search was incomplete and that the meta-analysis does not include a number of key studies which show that the protective effect of statins in women and men is remarkably similar in every category.<\/p>\n

Action Measure to Lower BP Among Diabetics (pg. 938):<\/strong>\u00a0 Pay for performance diverts effort from high risk patients who need it towards low risk patients who don\u2019t need it, and can even be harmed by it. This was demonstrated a couple of years ago with glycaemic control among British diabetics, and it\u2019s now demonstrated again in Americans with diabetes<\/a>\u2014this time in respect of blood pressure control. Over 700,000 diabetic patients were subject to an \u201caction measure\u201d by the Veterans\u2019 Administration that encouraged lowering of the systolic BP below 140 mm Hg. \u201cWhile 94% of diabetic veterans met the action measure, rates of potential overtreatment are currently approaching the rate of undertreatment, and high rates of achieving current threshold measures are directly associated with overtreatment.\u201d In other words, when \u201caction measures\u201d are imposed, low risk patients suffer the adverse effects of treatment to target. And these targets are generally derived from studies where the vast majority of the effect was derived from treating the patients at highest risk, as demonstrated by Timbie, Hayward and Vijan two years ago<\/a>.<\/p>\n

Prediction Tool for Initial Survivors of In-Hospital Cardiac Arrest (pg. 947):<\/strong>\u00a0 A group of notable US outcomes researchers<\/a> derive a beautifully predictive prediction tool for initial survivors of in-hospital cardiac arrest, based on the outcomes of 43,000 resuscitated patients. Its eleven points lie on a straight downward line. This time the invited commentary<\/a> is merely curmudgeonly, arguing that you\u2019re either dead or you aren\u2019t, so you mustn\u2019t give up on any group, even the ones with a 2.8% chance of surviving without neurological damage.<\/p>\n

Diagnosis and Treatment of Pulmonary Embolism (pg. 955):<\/strong>\u00a0 Now here\u2019s a lively, must-read paper<\/a> that you probably wouldn\u2019t find in any other main journal: not a review, not original research, not just an opinion piece\u2014but an intelligent examination of what we mean by pulmonary embolism and how this sheds light on the phenomena of diagnostic drift, overtreatment, and futile therapeutic innovation. \u201cTrials of newer anticoagulants and longer durations of anticoagulation have not yielded real improvements over heparin, inviting doubts regarding its efficacy. Thus, PE is the quintessential diagnosis of medicine not because it represents our greatest success, but because it captures all the complexity of medicine in the evidence-based era. It may serve as a metaphor for many other conditions in medicine, including coronary artery disease. New trials in the field continue to test trivialities, whereas fundamental questions are unanswered.\u201d Do try and get hold of it.<\/p>\n

Ann Intern Med\u00a0 3 July 2012\u00a0 Vol 157<\/strong><\/p>\n

Intervention to Prevent Medication Errors After Hospital Discharge (pg. 1):<\/strong>\u00a0 A trial to make you pause.<\/a> It was carried out in two leading academic hospitals in the USA using a highly labour-intensive intervention to prevent medication errors in the month following admission for an acute coronary event or acute heart failure. \u201cAmong 851 participants, 432 (50.8%) had 1 or more clinically important medication errors; 22.9% of such errors were judged to be serious and 1.8% life-threatening. Adverse drug events occurred in 258 patients (30.3%) and potential ADEs in 253 patients (29.7%).\u201d But the point is that the intervention made no difference at all, even though it was intelligently thought out and well executed, as far as one can tell. Moral: half of patients who are of above average \u201chealth literacy\u201d will suffer some kind of \u201cpreventable\u201d adverse drug event after a cardiac admission, and there is nothing we know of that will make any difference.<\/p>\n

Rehospitalization After Acute MI (pg. 11):<\/strong>\u00a0 So what does \u201cpreventable\u201d really mean in contexts like this? Many rehospitalizations following myocardial infarction are also deemed \u201cpreventable\u201d and preventing them is a quality of care indicator in several health systems. Here is an observational study<\/a> from little Olmsted county which went through the charts of 3,010 patients who were discharged following MI between 1987 and 2010. Just over 40% of the 643 readmissions were definitely MI-related: the rest were either definitely not or uncertainly related. Co-morbidity played a large role, and complications of revascularization were relatively common too. How truly preventable these readmissions were is not at all clear.<\/p>\n","protected":false},"excerpt":{"rendered":"

This week’s topics include sex differences in the protective effect of statins, an action measure to lower BP among diabetics, a prediction tool for initial survivors of in-hospital cardiac arrest, the diagnosis and treatment of pulmonary embolism, an intervention to prevent medication errors after hospital discharge, and rehospitalization after acute MI.<\/p>\n","protected":false},"author":475,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1131,456,317,200,1354,1353,596,1355,1352,584],"class_list":["post-30397","post","type-post","status-publish","format-standard","hentry","category-general","tag-acute-mi","tag-blood-pressure","tag-cardiac-arrest","tag-diabetes","tag-medication-errors","tag-prediction-tool","tag-pulmonary-embolism","tag-rehospitalization","tag-sex-differences","tag-statins"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/30397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/475"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=30397"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/30397\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=30397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=30397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=30397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}